Kiddy Meds

Hundreds of new drugs for kids are in the horizon

By | January 19, 2012

Dreamstime, Renata Osinska

DREAMSTIME, RENATA OSINSKA

In an effort to tailor healthcare to the unique physiological requirements of children, the pharmaceutical industry is researching 282 new children-specific medicines for a variety of diseases, including cancer, cystic fibrosis, epilepsy, and infectious diseases.

“These medicines offer hope that the significant improvements achieved in children’s health over the past few decades will continue and even accelerate,” said John J. Castellani, president of Pharmaceutical Research and Manufacturers of America (PhRMA), which issued the report, in a press release.

Many in the industry are also working to determine children-effective and safe dosages for existing treatments, in accordance with the Pediatric Research Equity and Best Pharmaceuticals for Children Acts, which require additional research into drugs for pediatric use.

Check back with The Scientist in March when two feature articles will explore the challenges of developing, testing, and prescribing drugs made to treat children.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Jon J. Tripp

Jon J. Tripp

Posts: 1

January 20, 2012

The report referenced in this story can be found at: http://bit.ly/zuxoUy. You can learn more about other medicines in development for a number of disease categories at: http://bit.ly/zwd5ER.

Avatar of:

Posts: 0

January 20, 2012

The report referenced in this story can be found at: http://bit.ly/zuxoUy. You can learn more about other medicines in development for a number of disease categories at: http://bit.ly/zwd5ER.

Avatar of:

Posts: 0

January 20, 2012

The report referenced in this story can be found at: http://bit.ly/zuxoUy. You can learn more about other medicines in development for a number of disease categories at: http://bit.ly/zwd5ER.

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham